1. Letter from the Editors

   Editorial Pages: 284 - 284

2. How much are health-care systems prepared to pay to produce a QALY?

   • Martin J. Buxton

   Editorial Pages: 285 - 287

3. Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris

   • Helen E. Campbell
   • Sue Tait
   • Martin J. Buxton

   Original Papers Pages: 288 - 297

   

4. Does testing for prostate-specific antigen contribute to declining prostate cancer mortality?

   • L. Di Matteo
   • R. Di Matteo

   Original Papers Pages: 298 - 308

   

5. Indirect costs of cervical and breast cancers in Spain

   • Juan Oliva
   • Félix Lobo
   • Rosa Romay

   Original Papers Pages: 309 - 313

6. Discrete choice experiments in health economics

   • Emily Lancsar
   • Cam Donaldson

   Original Papers Pages: 314 - 316

7. Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany

   • Werner Kulp
   • J.-M. Graf von der Schulenburg
   • Wolfgang Greiner

   Original papers Pages: 317 - 321

   

8. Hospital development plans

   • Steffen Fleßa

   Original Papers Pages: 322 - 333

   

9. Can economic evaluations be made more transferable?

   • Stephanie Boulenger
   • John Nixon
   • Gerard de Pouvourville

   Original Papers Pages: 334 - 346

10. Estimating utility data from clinical indicators for patients with stable angina

    • Louise Longworth
    • Martin J. Buxton
    • David H. Smith

    Original Papers Pages: 347 - 353

    

11. The cost-effectiveness of dual oral antiplatelet therapy following percutaneous coronary intervention

    • Anna Ringborg
    • Peter Lindgren
    • Bengt Jönsson

    Original papers Pages: 354 - 362